Evidence map›Paper›PMID 20521927›Full record

ArticleInternational reviews of immunology2010

Neonatal sepsis and neutrophil insufficiencies.

John Nicholas Melvan, Gregory J Bagby, David A Welsh, Steve Nelson, Ping Zhang

Open access · greenAbstract read
In one paragraph

Article in International reviews of immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Circulating DNA and Neutrophil-Derived Biomarkers in Neonatal Sepsis.International journal of molecular sciences · 2026
    Observational
  5. Necrotizing enterocolitis.Nature reviews. Disease primers · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. The emerging role of neutrophil extracellular traps in fungal infection.Frontiers in cellular and infection microbiology · 2022
    Review
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

John Nicholas MelvanDepartment of Physiology and Alcohol Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Gregory J Bagby
David A Welsh
Steve Nelson
Ping Zhang
Louisiana State University Health Sciences Center New Orleans · USPulmonary and Critical Care Associates · US

Funding

Translational Research/Education ComponentP60AA009803 · NIAAA · LSU HEALTH SCIENCES CENTER · PI DAVID A WELSH · 2004 to 2026
$42.6M
BIOMEDICAL ALCOHOL RESEARCH TRAINING PROGRAMT32AA007577 · NIAAA · LSU HEALTH SCIENCES CENTER · PI PATRICIA E. MOLINA · 1999 to 2026
$9.6M
PILOT--IMPACT OF ALCOHOLISM ON AIDS ASOCIATED MUSCLE WASTINGP50AA009803 · NIAAA · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI NELSON, STEVE · 1994 to 2003
$7.2M
Alcohol, Septicemia and the LKS Cell ResponseR01AA019676 · NIAAA · NORTHEAST OHIO MEDICAL UNIVERSITY · PI ZHANG, PING · 2010 to 2014
$1.7M
Alcohol and Impairment of the Granulopoietic Response to PneumoniaR21AA017494 · NIAAA · LSU HEALTH SCIENCES CENTER · PI ZHANG, PING · 2009 to 2010
$389k
Alcohol and Sca-1; Impairment of the granulopoietic precursor cell responseF30AA019586 · NIAAA · LSU HEALTH SCIENCES CENTER · PI MELVAN, JOHN NICHOLAS · 2010 to 2013
$114k
NIAAA NIH HHS AA017494NIAAA NIH HHS AA07577NIAAA NIH HHS AA09803NIAAA NIH HHS F30 AA019586NIAAA NIH HHS P50 AA009803NIAAA NIH HHS P60 AA009803NIAAA NIH HHS R01 AA019676NIAAA NIH HHS R21 AA017494NIAAA NIH HHS T32 AA007577
6 · The paper itself

Abstract

Sepsis has continuously been a leading cause of neonatal morbidity and mortality despite current advances in chemotherapy and patient intensive care facilities. Neonates are at high risk for developing bacterial infections due to quantitative and qualitative insufficiencies of innate immunity, particularly granulocyte lineage development and response to infection. Although antibiotics remain the mainstay of treatment, adjuvant therapies enhancing immune function have shown promise in treating sepsis in neonates. This article reviews current strategies for the clinical management of neonatal sepsis and analyzes mechanisms underlying insufficiencies of neutrophil defense in neonates with emphasis on new directions for adjuvant therapy development.

Indexed as

Antibiotic ProphylaxisChemotherapy, AdjuvantHumansImmunity, InnateInfant, NewbornNeutropeniaNeutrophilsSepsis

Identifiers

PMID20521927
PMCPMC3103186
OpenAlexW1985134279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.